Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets EXMKT - Delayed Quote USD

Pharmagen, Inc. (PHRX)

Compare
0.0000
0.0000
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Loading Chart for PHRX
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0001
  • Volume 2,399
  • Avg. Volume 2,166
  • Market Cap (intraday) 361,952
  • Beta (5Y Monthly) -0.47
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland.

24

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PHRX

View More

Performance Overview: PHRX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PHRX
90.00%
S&P 500 (^GSPC)
13.73%

1-Year Return

PHRX
90.00%
S&P 500 (^GSPC)
1.42%

3-Year Return

PHRX
0.00%
S&P 500 (^GSPC)
10.72%

5-Year Return

PHRX
97.50%
S&P 500 (^GSPC)
103.89%

Compare To: PHRX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PHRX

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -133.10%

  • Return on Assets (ttm)

    -58.91%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    4.41M

  • Net Income Avi to Common (ttm)

    -6.43M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    264.67k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    4.41M

Research Analysis: PHRX

View More

Company Insights: PHRX

Research Reports: PHRX

View More

People Also Watch